Abstract
During the past decade, diffuse intravascular coagulation (DIC) has been one of the most intensively studied subjects in hematology. DIC is a dynamic pathologic process caused by the entrance of foreign material into the circulation, or by exposure to abnormal surfaces. The intravascular coagulation is triggered by activation of the clotting cascade with resultant generation of excess thrombin within the vascular system that leads to further activation of the coagulation system, shortened survival of certain hemostatic elements, deposition of fibrin in the microcirculation, and activation of the fibrinolytic system. Decreased levels of hemostatic factors, secondary fibrinolysis, and exhaustion of the physiologic inhibitors (AT III and SRE) may result in clinically excessive bleeding, particularly when the patient’s blood vessels have been damaged. In contrast, fibrin deposition may cause micro- or macro-thrombosis, and occasionally results in a fragmentation-type hemolytic anemia (Fig. 1).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
E. Anker, U. Abilgaard, R. Andersen, M. Fagerol, and G. Bjune, Low antithrombin in severe disease: consumption or decreased synthesis? Scand. J. Haemtol., 30(Suppl. 39): 59–63 (1983).
J. Bernard, Acute promyelocytic leukemia, Proc. 3rd International Symposium on Therapy of Acute Leukemias, Rome, December 11–14 (1982).
B. Blauhut, S. Necek, H. Vinazzer, and H. Bergmann, Substistitution therapy with ATIII concentrate in shock and DIC, Thromb. Res., 27: 271 (1982).
B. Bonen, P. Sie, C. Caranobe, and J. Guittard, Plasma anti-thrombins during heparin therapy, Thromb. Res., 27: 123 (1982).
P. Citarrella, R. Perricone, V. Abbadessa, I. Carreca, M. Pecorella, P. Di Marco, and A. Cajozzo, Initial therapeutical management of acute promyelocytic leukaemia (APL): results of 12 cases, Haematologica, 64: 339 (1979).
C.J. Diskin and A.B. Weitberg, Treatment of chronic intravascular coagulation syndrome, Arch. Intern. Med., 140: 263 (1980).
M.B. Donati and E. Vincenzi, Tumori ed emostasi, Atti VIII Corso Nazionale di Aggiornamento in Ematologia Clinica, Brisighella, April 22-25, p. 511 (1982).
D.I. Feinstein, Diagnosis and management of disseminated intravascular coagulation. The role of heparin therapy, Blood, 60: 284 (1981).
G. Gamba, G. Grignani, M. Biancardi, D. Geraldi, and E. Ascari, Acute leukemias and DIC: effectiveness of treatment with low doses of heparin, Haematologica, 64: 322 (1979).
G.M. Gandolfo and M.V. Torresi, “Antitrombina III,” Piccin, Padova (1981).
L. Gugliotti, S. Viganò, A. Guarini, B. Timoncini, P.M. Mannucci, and S. Tura, Disseminated intravascular coagulation and fibrinopeptide A in adult acute myeloid leukemia, Proc. 3rd International Symposium on Therapy of Acute Leukemias, Rome, December 11–14 (1982).
H.S. Jacobs, P.R. Craddock, D.E. Hammerschmidt, and C.F. Maldow, Complement-induced granulocyte aggregation, N. Engl. J. Med., 302: 789 (1980).
I. Majolino, G. Nalli, P. Panizza, L. Cervini, and E. Ascari, Antitrombina III: fisiopatologia e clinica, Haematologica, 64: 322 (1979).
P.M. Mannucci, Effect on blood coagulation of massive intravascular haemolysis, Blood, 33: 207 (1969).
E. Marciniak and J.P. Gockerman, Heparin-induced decrease in circulating antithrombin III, Lancet, ii: 581 (1977).
G.G. Neri Serneri, G.F. Gensini, and R. Abbate, High molecular weight fibrinogen complexes in the assessment of hypercoagulability, in; “Haemostasis and Thrombosis,” G.G. Neri Serneri and C.R.M. Prentice, eds., Academic Press, London, p. 123 (1979).
M.C. Petti, S. Amadori, G. Awisati, M. Baccarani, A. Cafolla, D. Ruggero, S. Tura, and F. Mandelli, Acute promyelocytic leukemia. A collaborative study of 62 patients, Proc. 3rd International Symposium on Therapy of Acute Leukemias, Rome, December 11–14 (1982).
T. Siegal, U. Seligsohn, E. Aghai, and M. Modan, Clinical and laboratory aspects of disseminated intravascular coagulation (DIC), Thromb. Haemost., 39: 122 (1978).
G.F. Smith and J.L. Sundboom, Heparin and protease inhibition II. The role of heparin in the ATIII inactivation of thrombin, plasmin, and trypsin, Thromb. Res., 22: 115–133 (1981).
J.A. Spero, J.H. Lewis, and U. Hasiba, Disseminated intravascular coagulation, Thromb. Haemost., 38: 33 (1980).
J.A. Van Mourik, The significance of fibrinopeptide A (FPA) in the diagnosis of low grade intravascular coagulation and venous thromboembolism, Haematologica, 66: 259 (1981).
M.M. Wintrobe, G.R. Lee, D.R. Boggs, T.C. Bithell, J. Foerster, J.W. Athens, and J.N. Lukens, Acquired coagulation disorders, in: “Clinical Haematology,” Lea and Febiger, Philadelphia, p. 1213 (1981).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Plenum Press, New York
About this chapter
Cite this chapter
Citarrella, P., Cajozzo, A. (1985). Disseminated Intravascular Coagulation. In: Cajozzo, A., Perricone, R., Di Marco, P., Palazzolo, P. (eds) Advances in Hemostasis and Thrombosis. Ettore Majorana International Science Series, vol 20. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-9424-6_29
Download citation
DOI: https://doi.org/10.1007/978-1-4615-9424-6_29
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-9426-0
Online ISBN: 978-1-4615-9424-6
eBook Packages: Springer Book Archive